Generating Novel Linker Structures in Antibody-Drug Conjugates with Diffusion Models
1. 系统已在2025-08-21 11:51:19对应助文件进行删除
2. 如有需要请重新发布求助信息
注: 所有应助的资源仅供学习交流使用, 不得违反相关法律法规
DOI:
文献链接:
其他信息:
A Cao, JY Chen
International Conference on Artificial Intelligence in …, 2025
Springer
Antibody-drug conjugates (ADCs) are innovative cancer therapies composed of three main components: a monoclonal antibody, payload, and linker. The linker plays a crucial role in ADC pharmacokinetics and payload release. Current challenges in linker design stem from the need to balance complex requirements, including stability, controlled release, toxicity profile, biological context, linker length, and steric hindrance. Leveraging computational tools, particularly generative models, offers a path to explore chemical space and design …